IBDEI0BC ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5119,1,3,0)
 ;;=3^Volume Depletion,Unspec
 ;;^UTILITY(U,$J,358.3,5119,1,4,0)
 ;;=4^E86.9
 ;;^UTILITY(U,$J,358.3,5119,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,5120,0)
 ;;=E86.0^^27^330^6
 ;;^UTILITY(U,$J,358.3,5120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5120,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,5120,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,5120,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,5121,0)
 ;;=E86.1^^27^330^22
 ;;^UTILITY(U,$J,358.3,5121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5121,1,3,0)
 ;;=3^Hypovolemia
 ;;^UTILITY(U,$J,358.3,5121,1,4,0)
 ;;=4^E86.1
 ;;^UTILITY(U,$J,358.3,5121,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,5122,0)
 ;;=E87.70^^27^330^11
 ;;^UTILITY(U,$J,358.3,5122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5122,1,3,0)
 ;;=3^Fluid Overload,Unspec
 ;;^UTILITY(U,$J,358.3,5122,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,5122,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,5123,0)
 ;;=E87.5^^27^330^14
 ;;^UTILITY(U,$J,358.3,5123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5123,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,5123,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,5123,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,5124,0)
 ;;=E87.6^^27^330^20
 ;;^UTILITY(U,$J,358.3,5124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5124,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,5124,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,5124,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,5125,0)
 ;;=E87.8^^27^330^8
 ;;^UTILITY(U,$J,358.3,5125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5125,1,3,0)
 ;;=3^Electrolyte & Fluid Balance Disorders NEC
 ;;^UTILITY(U,$J,358.3,5125,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,5125,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,5126,0)
 ;;=E26.81^^27^330^5
 ;;^UTILITY(U,$J,358.3,5126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5126,1,3,0)
 ;;=3^Bartter's Syndrome
 ;;^UTILITY(U,$J,358.3,5126,1,4,0)
 ;;=4^E26.81
 ;;^UTILITY(U,$J,358.3,5126,2)
 ;;=^329906
 ;;^UTILITY(U,$J,358.3,5127,0)
 ;;=E23.2^^27^330^7
 ;;^UTILITY(U,$J,358.3,5127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5127,1,3,0)
 ;;=3^Diabetes Insipidus
 ;;^UTILITY(U,$J,358.3,5127,1,4,0)
 ;;=4^E23.2
 ;;^UTILITY(U,$J,358.3,5127,2)
 ;;=^33572
 ;;^UTILITY(U,$J,358.3,5128,0)
 ;;=E83.41^^27^330^15
 ;;^UTILITY(U,$J,358.3,5128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5128,1,3,0)
 ;;=3^Hypermagnesemia
 ;;^UTILITY(U,$J,358.3,5128,1,4,0)
 ;;=4^E83.41
 ;;^UTILITY(U,$J,358.3,5128,2)
 ;;=^5003002
 ;;^UTILITY(U,$J,358.3,5129,0)
 ;;=E21.3^^27^330^17
 ;;^UTILITY(U,$J,358.3,5129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5129,1,3,0)
 ;;=3^Hyperparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,5129,1,4,0)
 ;;=4^E21.3
 ;;^UTILITY(U,$J,358.3,5129,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,5130,0)
 ;;=E83.42^^27^330^21
 ;;^UTILITY(U,$J,358.3,5130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5130,1,3,0)
 ;;=3^Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,5130,1,4,0)
 ;;=4^E83.42
 ;;^UTILITY(U,$J,358.3,5130,2)
 ;;=^5003003
 ;;^UTILITY(U,$J,358.3,5131,0)
 ;;=N25.1^^27^330^25
 ;;^UTILITY(U,$J,358.3,5131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5131,1,3,0)
 ;;=3^Nephrogenic Diabetes Insipidus
 ;;^UTILITY(U,$J,358.3,5131,1,4,0)
 ;;=4^N25.1
 ;;^UTILITY(U,$J,358.3,5131,2)
 ;;=^5015616
 ;;^UTILITY(U,$J,358.3,5132,0)
 ;;=E27.49^^27^330^2
 ;;^UTILITY(U,$J,358.3,5132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5132,1,3,0)
 ;;=3^Adrenocortical Insufficiency,Other
 ;;^UTILITY(U,$J,358.3,5132,1,4,0)
 ;;=4^E27.49
 ;;^UTILITY(U,$J,358.3,5132,2)
 ;;=^5002743
 ;;^UTILITY(U,$J,358.3,5133,0)
 ;;=E72.09^^27^330^4
